| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/28/2023 | Cellectar Biosciences, Inc. | CLRB | Grant | Stock option (right to buy) | 25k | $1.85 | $46.2k | | 06/28/2023 |
| 01/03/2023 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 10k | $2.66 | $26.6k | | 01/03/2023 |
| 07/05/2022 | MEI Pharma, Inc. | MEIP | Grant | Stock Option (Right to Buy) | 87.5 | $0.54 | $47.2 | | 07/05/2022 |
| 06/24/2022 | Cellectar Biosciences, Inc. | CLRB | Grant | Stock option (right to buy) | 7.8k | $0.00 | $0 | | 06/24/2022 |
| 03/28/2022 | Renovacor, Inc. | CHAQ | Grant | Option | 155.3k | $4.30 | $667.9k | | 03/28/2022 |
| 01/03/2022 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 10k | $12.28 | $122.8k | | 01/03/2022 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Stock option (right to buy) | 168k | $8.35 | $1.4M | | 11/19/2021 |
| 11/19/2021 | Flexion Therapeutics Inc | FLXN | Disposition | Common Stock | 30.7k | $8.50 | $260.8k | | 11/19/2021 |
| 09/03/2021 | Cellectar Biosciences, Inc. | CLRB | Purchase | Common Stock | 19.4k | $1.04 | $20.2k | | 09/03/2021 |
| 07/01/2021 | MEI Pharma, Inc. | MEIP | Grant | Stock Option (Right to Buy) | 50k | $2.95 | $147.5k | | 07/01/2021 |
| 06/01/2021 | Flexion Therapeutics Inc | FLXN | Grant | Common Stock | 28k | $0.00 | $0 | | 06/01/2021 |
| 06/01/2021 | Flexion Therapeutics Inc | FLXN | Grant | Stock option (right to buy) | 168k | $8.35 | $1.4M | | 06/01/2021 |
| 02/23/2021 | MEI Pharma, Inc. | MEIP | Sale | Common Stock | 25k | $4.03 | $100.6k | | 02/23/2021 |
| 01/04/2021 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 10k | $12.36 | $123.6k | | 01/04/2021 |
| 08/11/2020 | ImmunityBio, Inc. | NK | Sale | Common Stock | 10k | $9.98 | $99.8k | | 08/11/2020 |
| 08/11/2020 | ImmunityBio, Inc. | NK | Sale | Common Stock | 5.3k | $10.77 | $57.1k | | 08/11/2020 |
| 08/11/2020 | ImmunityBio, Inc. | NK | Sale | Common Stock | 50k | $10.22 | $511.2k | | 08/11/2020 |
| 07/02/2020 | MEI Pharma, Inc. | MEIP | Grant | Stock Option (Right to Buy) | 50k | $3.49 | $174.5k | | 07/02/2020 |
| 06/24/2020 | Cellectar Biosciences, Inc. | CLRB | Grant | Stock option (right to buy) | 50k | $1.28 | $64k | | 06/24/2020 |
| 06/10/2020 | ImmunityBio, Inc. | NK | Grant | Stock Option (right to buy) | 100k | $6.21 | $621k | | 06/10/2020 |
| 01/02/2020 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 8k | $16.31 | $130.5k | | 01/02/2020 |
| 12/19/2019 | MEI Pharma, Inc. | MEIP | Purchase | Common Stock | 62.5k | $1.60 | $100k | | 12/19/2019 |
| 07/01/2019 | MEI Pharma, Inc. | MEIP | Grant | Stock Option (Right to Buy) | 40k | $2.52 | $100.8k | | 07/01/2019 |
| 06/13/2019 | Cellectar Biosciences, Inc. | CLRB | Grant | Stock option (right to buy) | 6.5k | $2.15 | $14k | | 06/13/2019 |
| 06/06/2019 | ImmunityBio, Inc. | NK | Grant | | 92.6k | $0.00 | $0 | | 06/06/2019 |
| 01/02/2019 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 8k | $5.16 | $41.3k | | 01/02/2019 |
| 10/12/2018 | Cellectar Biosciences, Inc. | CLRB | Grant | Stock option (right to buy) | 13k | $2.61 | $33.9k | | 10/12/2018 |
| 07/12/2018 | MEI Pharma, Inc. | MEIP | Grant | Stock Option (Right to Buy) | 40k | $4.28 | $171.2k | | 07/12/2018 |
| 06/26/2018 | Cue Biopharma, Inc. | CUE | Grant | Stock Option (right to buy) | 50k | $12.97 | $648.5k | | 06/26/2018 |
| 06/07/2018 | ImmunityBio, Inc. | NK | Grant | | 27.3k | $0.00 | $0 | | 06/07/2018 |
| 02/22/2018 | MEI Pharma, Inc. | MEIP | Grant | Options to purchase shares of common stock | 33.3k | $2.19 | $73k | | 02/22/2018 |
| 09/18/2017 | ImmunityBio, Inc. | NK | Grant | Common Stock | 54.6k | $0.00 | $0 | | 09/18/2017 |
| 05/31/2017 | Cellectar Biosciences, Inc. | CLRB | Grant | Stock option (right to buy) | 10k | $1.74 | $17.4k | | 05/31/2017 |
| 03/23/2017 | Flexion Therapeutics Inc | FLXN | Exercise | Stock option (right to buy) | 3k | $7.89 | $23.7k | | 03/23/2017 |
| 03/23/2017 | Flexion Therapeutics Inc | FLXN | Sale | Common Stock | 3k | $23.00 | $69k | | 03/23/2017 |
|